Levi & Korsinsky Notifies Merck & Co., Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MRK
Portfolio Pulse from
Levi & Korsinsky law firm has initiated a class action securities lawsuit against Merck (MRK) alleging securities fraud related to Gardasil sales projections in China. The lawsuit claims Merck misrepresented expected revenue of $11 billion from Gardasil by 2030. On February 4, 2025, Merck announced it would cease Gardasil shipments to China, causing the stock to drop over 9% in a single day.
March 21, 2025 | 10:00 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
The class action lawsuit alleges securities fraud regarding Gardasil sales projections in China, which could result in financial penalties and investor trust erosion.
The lawsuit directly targets Merck's representations about Gardasil sales, alleging material misstatements that caused investor losses. The 9% stock drop and potential legal penalties suggest significant short-term negative impact.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100